Kura Oncology Inc (NASDAQ: KURA) is 44.51% higher on its value in year-to-date trading and has touched a low of $7.41 and a high of $24.17 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The KURA stock was last observed hovering at around $20.36 in the last trading session, with the day’s gains setting it 0.42%.
Currently trading at $20.78, the stock is -1.32% and -1.96% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.82 million and changing 2.06% at the moment leaves the stock 21.31% off its SMA200. KURA registered 107.59% gain for a year compared to 6-month gain of 5.97%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 1.42% loss in the last 1 month and extending the period to 3 months gives it a 10.83%, and is -3.35% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.74% over the week and 4.10% over the month.
Kura Oncology Inc (KURA) has around 142 employees, a market worth around $1.58B and $0.00M in sales. Distance from 52-week low is 180.43% and -14.03% from its 52-week high. The company has generated returns on investments over the last 12 months (-32.28%).
The EPS is expected to shrink by -21.65% this year
The shares outstanding are 74.35M, and float is at 64.74M with Short Float at 13.74%.
Kura Oncology Inc (KURA) Insider Activity
The most recent transaction is an insider sale by Bair Teresa Brophy, the company’s Chief Legal Officer. SEC filings show that Bair Teresa Brophy sold 2,615 shares of the company’s common stock on May 20 ’24 at a price of $22.15 per share for a total of $57916.0. Following the sale, the insider now owns 68979.0 shares.
Kura Oncology Inc disclosed in a document filed with the SEC on Jan 30 ’24 that DALE STEPHEN (Chief Medical Officer) sold a total of 4,825 shares of the company’s common stock. The trade occurred on Jan 30 ’24 and was made at $21.55 per share for $0.1 million. Following the transaction, the insider now directly holds 38817.0 shares of the KURA stock.
Still, SEC filings show that on Jan 29 ’24, DALE STEPHEN (Chief Medical Officer) disposed off 7,158 shares at an average price of $17.80 for $0.13 million. The insider now directly holds 43,642 shares of Kura Oncology Inc (KURA).